Milad Nazarzadeh
DPHIL STUDENT
- PI Group: Dr Kazem Rahimi
Milad Nazarzadeh is a third year DPhil student at the University of Oxford with a scholarship from the British Heart Foundation. His project focuses on the effect of blood pressure-lowering drugs and drug-drug interactions on the risk of type 2 diabetes through integrating epidemiologic and genetic data, supervised by Prof Kazem Rahimi, Dr Dexter Canoy, Dr Abbas Dehghan, Dr Derrick Bennett and Prof George Davey Smith.
Milad completed his BSc of Public Health at the Zanjan University of Medical Sciences, Iran, then received his MSc of Epidemiology from Shahid Beheshti University of Medical Science, Tehran, Iran. He was faculty member, lecturer and research director at University of Medical Sciences, Iran (Sabzevar and Torbat Heydarieh, 2015- 2017). Then, he joined The George Institute for Global Health, UK at the University of Oxford as Epidemiologist (2017-2019). Also, he is currently Associate Editor of the BMC Cardiovascular Disorders. His research interests include blood pressure, cardiovascular disease and Pharmacogenetics, using methodologies such as systematic review and meta-analysis, advanced statistical modelling, individual-patient meta-analysis and Mendelian Randomisation.
Recent publications
-
Journal article
Canoy D. et al, (2022), Current Cardiology Reports
-
Journal article
Mousavi SF. et al, (2022), Seizure, 97, 58 - 62
-
Journal article
Nazarzadeh M. et al, (2022), J Hypertens
-
Journal article
Canoy D. et al, (2022), Heart
-
Journal article
Teymoori F. et al, (2022), Journal of Diabetes and Metabolic Disorders
-
Journal article
Nazarzadeh M. et al, (2021), Lancet, 398, 1803 - 1810
-
Journal article
Rahimi K. et al, (2021), Lancet, 398, 1684 - 1685
-
Elevated blood pressure, antihypertensive medications and bone health in the population: Revisiting old hypotheses and exploring future research directions
Journal article
CANOY D. et al, (2021), Osteoporosis International
-
Journal article
Blood Pressure Lowering Treatment Trialists' Collaboration None., (2021), Lancet, 398, 1053 - 1064
-
Age and blood pressure stratified effects of blood pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual-level meta-analysis of 358,707 randomised participants
Journal article
MCMANUS R. et al, (2021), The Lancet